The report "Neurovascular
Devices/Interventional Neurology Market by Product (Embolic Coils,
Stents, Neurothrombectomy Devices, Microcatheters, Balloon Occlusion Devices,
Flow Diversion Devices, Clot Retrievers), Pathology (Aneurysm, AVM) - Global
Forecasts to 2021", This report studies the neurovascular
devices/interventional neurology market over the forecast period of 2016 to
2021. The market is expected to reach USD 2.62 Billion by 2021 at a CAGR of
8.6% during 2016 to 2021.
Browse 100 market data
tables and 52 figures spread through 193 pages and in-depth TOC on "Neurovascular Devices/Interventional
Neurology Markert “
Early buyers
will receive 10% customization on This reports.
A number of factors
such as growing target patient population, ongoing product development &
commercialization, favorable medical reimbursements, expansion of healthcare
infrastructure across emerging markets, growing market demand for effective
neurovascular devices, increasing number of researches in the field of
neurovascular therapies, rising demand for minimally invasive neurosurgical
procedures, and increasing awareness among neurosurgeons about minimally
invasive surgical procedures. However, dearth of skilled neurosurgeons and
stringent regulatory policies are the key challenges faced by leading players
in the global neurovascular devices/interventional neurology market.
On the basis of products, the
neurovascular devices/interventional neurology market is segmented into
aneurysm coiling and embolization devices, cerebral balloon angioplasty and
stenting systems, support devices, and neurothrombectomy devices. The aneurysm
coiling and embolization devices segment is expected to hold the largest share
of the interventional neurology market in 2016. The large market share of this
segment can be attributed to the growing end-user preference for minimally
invasive neurosurgical procedures and increasing market availability of embolic
coils for neurovascular treatment.
On the basis of pathology, the
neurovascular devices/interventional neurology market is segmented into
ischemic strokes, cerebral aneurysm, arteriovenous malformations &
fistulas, and other diseases. The ischemic strokes segment is expected to hold
the largest share of the global neurovascular devices/interventional neurology
market in 2016. Dominant market position of ischemic strokes segment is
attributed to rising prevalence of ischemic stroke (coupled with exposure of
larger proportion of global population to major risk factors such as smoking
and diabetes), and increasing patient preference for minimally invasive
therapeutic neurosurgical technologies.
On the basis of geography, this market
is classified into four regions, namely, North America, Europe, Asia-Pacific,
and the Rest of the World. In 2016, the global interventional neurology market
is expected to be dominated by North America. North American region is expected
to dominate the neurovascular devices/interventional neurology market during
study period owing to significant adoption of neurovascular devices among
neurosurgeons in neurovascular disease treatment, growing number of clinical
trials (that aim to evaluate the therapeutic efficacy of neurovascular devices)
and significant medical reimbursement available in the U.S. for neurosurgical
procedures.
The Sample Report For This Report@
New product launches and enhancements
are the key growth strategies adopted by major players to develop their
positions in the global neurovascular devices/interventional neurology market.
Moreover, strategies such as agreements and collaborations; strategic
acquisitions; and market expansions were also adopted by a significant number
of market players to strengthen their product portfolios, distribution networks
and expand their geographic presence in the global neurovascular
devices/interventional neurology market.
As of 2015, Stryker Corporation (U.S.),
Medtronic plc (U.S.), Johnson & Johnson (U.S.), and Terumo Corporation
(Japan) are the top four players in the market. Other prominent players present
in the market include Penumbra, Inc. (U.S.), Abbott Laboratories (U.S.), Merit
Medical Systems, Inc. (U.S.), W. L. Gore & Associates, Inc. (U.S.), and
MicroPort Scientific Corporation (China), among others.
Get The
PDF Brochure For This Report@
About MarketsandMarkets™:
MarketsandMarkets™
provides quantified B2B research on 30,000 high growth niche
opportunities/threats which will impact 70% to 80% of worldwide companies’
revenues. Currently servicing 5000 customers worldwide including 80% of global
Fortune 1000 companies as clients. Almost 75,000 top officers across eight
industries worldwide approach MarketsandMarkets™ for their painpoints around
revenues decisions.
Our
850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high
growth markets following the "Growth Engagement Model – GEM". The GEM
aims at proactive collaboration with the clients to identify new opportunities,
identify most important customers, write "Attack, avoid and defend"
strategies, identify sources of incremental revenues for both the company and
its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants
(Positioning top players across leaders, emerging companies, innovators,
strategic players) annually in high growth emerging segments.
MarketsandMarkets™ is determined to benefit more than 10,000 companies this
year for their revenue planning and help them take their
innovations/disruptions early to the market by providing them research ahead of
the curve.
MarketsandMarkets’s
flagship competitive intelligence and market research platform, "RT"
connects over 200,000 markets and entire value chains for deeper understanding
of the unmet insights along with market sizing and forecasts of niche
markets.
Contact:
Mr. Rohan
MarketsandMarkets™
701
Pike Street
Suite
2175, Seattle,
WA
98101, United States
Tel:
1-888-600-6441
No comments:
Post a Comment